Transcatheter innovations in tricuspid regurgitation: Cardioband

Antonio Mangieri; Azeem Latib

doi:10.1016/j.pcad.2019.10.002

Transcatheter innovations in tricuspid regurgitation: Cardioband

Antonio Mangieri, Azeem Latib

Medicine

Research output: Contribution to journal › Review article › peer-review

5 Scopus citations

Abstract

Functional tricuspid regurgitation (FTR) has been neglected for a long time, however its prevalence and clinical relevance is not negligible. In presence of FTR, a certain quote of annular dilatation is present thus contributing to the mechanism of regurgitation. Historically, surgical annuloplasty has been the main treatment to correct FTR; however surgical repair is limited by a high risk of mortality and morbidity. For this reason, percutaneous tricuspid annuloplasty is an attractive tool for the treatment of FTR in patients at high surgical risk. A number of both direct and indirect percutaneous annuloplasty systems are currently under pre-clinical and clinical development. This review will discuss the Cardioband system, a novel direct annuloplasty device with promising result in terms of clinical safety and efficacy.

Original language	English (US)
Pages (from-to)	482-485
Number of pages	4
Journal	Progress in Cardiovascular Diseases
Volume	62
Issue number	6
DOIs	https://doi.org/10.1016/j.pcad.2019.10.002
State	Published - Nov 1 2019

Keywords

Functional tricuspid regurgitation
Percutaneous tricuspid annuloplasty
Tricuspid regurgitation

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.pcad.2019.10.002

Cite this

@article{161a1c1b489a41ad8657ae4efbdf90a5,

title = "Transcatheter innovations in tricuspid regurgitation: Cardioband",

abstract = "Functional tricuspid regurgitation (FTR) has been neglected for a long time, however its prevalence and clinical relevance is not negligible. In presence of FTR, a certain quote of annular dilatation is present thus contributing to the mechanism of regurgitation. Historically, surgical annuloplasty has been the main treatment to correct FTR; however surgical repair is limited by a high risk of mortality and morbidity. For this reason, percutaneous tricuspid annuloplasty is an attractive tool for the treatment of FTR in patients at high surgical risk. A number of both direct and indirect percutaneous annuloplasty systems are currently under pre-clinical and clinical development. This review will discuss the Cardioband system, a novel direct annuloplasty device with promising result in terms of clinical safety and efficacy.",

keywords = "Functional tricuspid regurgitation, Percutaneous tricuspid annuloplasty, Tricuspid regurgitation",

author = "Antonio Mangieri and Azeem Latib",

note = "Publisher Copyright: {\textcopyright} 2019",

year = "2019",

month = nov,

day = "1",

doi = "10.1016/j.pcad.2019.10.002",

language = "English (US)",

volume = "62",

pages = "482--485",

journal = "Progress in Cardiovascular Diseases",

issn = "0033-0620",

publisher = "W.B. Saunders Ltd",

number = "6",

}

TY - JOUR

T1 - Transcatheter innovations in tricuspid regurgitation

T2 - Cardioband

AU - Mangieri, Antonio

AU - Latib, Azeem

PY - 2019/11/1

Y1 - 2019/11/1

N2 - Functional tricuspid regurgitation (FTR) has been neglected for a long time, however its prevalence and clinical relevance is not negligible. In presence of FTR, a certain quote of annular dilatation is present thus contributing to the mechanism of regurgitation. Historically, surgical annuloplasty has been the main treatment to correct FTR; however surgical repair is limited by a high risk of mortality and morbidity. For this reason, percutaneous tricuspid annuloplasty is an attractive tool for the treatment of FTR in patients at high surgical risk. A number of both direct and indirect percutaneous annuloplasty systems are currently under pre-clinical and clinical development. This review will discuss the Cardioband system, a novel direct annuloplasty device with promising result in terms of clinical safety and efficacy.

AB - Functional tricuspid regurgitation (FTR) has been neglected for a long time, however its prevalence and clinical relevance is not negligible. In presence of FTR, a certain quote of annular dilatation is present thus contributing to the mechanism of regurgitation. Historically, surgical annuloplasty has been the main treatment to correct FTR; however surgical repair is limited by a high risk of mortality and morbidity. For this reason, percutaneous tricuspid annuloplasty is an attractive tool for the treatment of FTR in patients at high surgical risk. A number of both direct and indirect percutaneous annuloplasty systems are currently under pre-clinical and clinical development. This review will discuss the Cardioband system, a novel direct annuloplasty device with promising result in terms of clinical safety and efficacy.

KW - Functional tricuspid regurgitation

KW - Percutaneous tricuspid annuloplasty

KW - Tricuspid regurgitation

UR - http://www.scopus.com/inward/record.url?scp=85076852748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076852748&partnerID=8YFLogxK

U2 - 10.1016/j.pcad.2019.10.002

DO - 10.1016/j.pcad.2019.10.002

M3 - Review article

C2 - 31669500

AN - SCOPUS:85076852748

SN - 0033-0620

VL - 62

SP - 482

EP - 485

JO - Progress in Cardiovascular Diseases

JF - Progress in Cardiovascular Diseases

IS - 6

ER -

Transcatheter innovations in tricuspid regurgitation: Cardioband

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this